• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Alcon to acquire WaveTec Vision, ORA System


Alcon Laboratories has entered into an agreement to acquire WaveTec Vision.

Fort Worth, TX-Alcon Laboratories has entered into an agreement to acquire WaveTec Vision.

Through the agreement, Alcon will also obtain full rights to WaveTec Vision’s ORA System, an intraoperative guidance system for cataract surgeons implanting IOLs.

More in this issue: Examining the impact of poor vision in a hospital setting

Alcon plans to integrate the guidance system into its existing cataract refractive suit, which includes:

·      Verion image-guided preoperative diagnostic system

·      LenSx femtosecond laser

·      Centurion phacoemulsification system

·      LuxOR LX3 microscrope


“Alcon is continuously seeking new ways to address the needs of cataract patients, particularly those who live with astigmatism and presbyopia,” said Jeff George, global head of Alcon. “The (guidance) system provides intraoperative measurements which are not available with current preoperative technologies and is designed to help surgeons improve patient outcomes through optimal IOL selection and placement during surgery.”

More in this issue: Allergan treatment for DME extended in EU

According to the company, the marriage of the guidance system and Alcon’s Verion imaged-guided system is intended to increase the surgeon’s clinical confidence when using IOLs. Ultimately, the combined technologies are designed to improve patient outcomes and enhance the overall post-surgical patient experience with IOLs.

“The (guidance) system has proven that there is real value in technology that is both patient- and provider-centered,” said Tom Frinzi, WaveTec president and chief executive officer.

Upon closing, Alcon will immediately begin the integration of the company into its surgical business franchise. The transaction is subject to closing conditions, including anti-trust approval.



For more articles in this issue of Ophthalmology Times eReport, click here.

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.